Influence of intravenous contrast agent on dose calculations of intensity modulated radiation therapy plans for head and neck cancer
To access this article, please choose from the options below
PII: S0167-8140(06)00487-7
doi:10.1016/j.radonc.2006.09.010
© 2006 Elsevier Ireland Ltd. All rights reserved.
